JP2018526459A - 脊椎関節症の処置のためのインターロイキン−２の使用 - Google Patents

脊椎関節症の処置のためのインターロイキン−２の使用 Download PDF

Info

Publication number
JP2018526459A
JP2018526459A JP2018532806A JP2018532806A JP2018526459A JP 2018526459 A JP2018526459 A JP 2018526459A JP 2018532806 A JP2018532806 A JP 2018532806A JP 2018532806 A JP2018532806 A JP 2018532806A JP 2018526459 A JP2018526459 A JP 2018526459A
Authority
JP
Japan
Prior art keywords
interleukin
treatment
use according
administered
spondyloarthropathy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018532806A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018526459A5 (enExample
Inventor
ダヴィッド・クラッツマン
フランシス・ベレンバウム
ジェレミー・セラム
ブルーノ・フォートレル
ロベルタ・ロレンゾン
パトリス・カクー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iltoo Pharma
Assistance Publique - Hôpitaux de Paris
Sorbonne Université
Original Assignee
Iltoo Pharma
Assistance Publique - Hôpitaux de Paris
Sorbonne Université
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iltoo Pharma, Assistance Publique - Hôpitaux de Paris, Sorbonne Université filed Critical Iltoo Pharma
Publication of JP2018526459A publication Critical patent/JP2018526459A/ja
Publication of JP2018526459A5 publication Critical patent/JP2018526459A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2018532806A 2015-09-10 2016-09-09 脊椎関節症の処置のためのインターロイキン−２の使用 Pending JP2018526459A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15306383 2015-09-10
EP15306383.9 2015-09-10
PCT/EP2016/071370 WO2017042370A1 (en) 2015-09-10 2016-09-09 Use of interleukin 2 for treating spondyloarthritis

Publications (2)

Publication Number Publication Date
JP2018526459A true JP2018526459A (ja) 2018-09-13
JP2018526459A5 JP2018526459A5 (enExample) 2019-10-17

Family

ID=54145708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018532806A Pending JP2018526459A (ja) 2015-09-10 2016-09-09 脊椎関節症の処置のためのインターロイキン−２の使用

Country Status (6)

Country Link
US (1) US20190060407A1 (enExample)
EP (1) EP3347036A1 (enExample)
JP (1) JP2018526459A (enExample)
AU (1) AU2016319292A1 (enExample)
CA (1) CA2997946A1 (enExample)
WO (1) WO2017042370A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102777151B1 (ko) 2017-11-21 2025-03-05 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 인터루킨-2의 부분 효능제
EP3752178A1 (en) * 2018-02-16 2020-12-23 Iltoo Pharma Use of interleukin 2 for treating sjögren's syndrome
WO2020007937A1 (en) * 2018-07-03 2020-01-09 Iltoo Pharma Use of interleukin-2 for treating systemic sclerosis
KR20210039403A (ko) 2018-08-01 2021-04-09 타리스 바이오메디컬 엘엘씨 트로스피움을 사용한 과민성 방광의 치료 방법
CN115362168A (zh) 2020-01-14 2022-11-18 辛德凯因股份有限公司 偏向化il2突变蛋白方法和组合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014510725A (ja) * 2011-03-11 2014-05-01 アシスタンス ピュブリク−オピトー ドゥ パリ 自己免疫関連障害または炎症性障害の治療のための低用量ｉｌ−２の使用
CN104189892A (zh) * 2014-08-22 2014-12-10 北京大学人民医院 低剂量白细胞介素2在免疫相关性疾病治疗中的应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014510725A (ja) * 2011-03-11 2014-05-01 アシスタンス ピュブリク−オピトー ドゥ パリ 自己免疫関連障害または炎症性障害の治療のための低用量ｉｌ−２の使用
CN104189892A (zh) * 2014-08-22 2014-12-10 北京大学人民医院 低剂量白细胞介素2在免疫相关性疾病治疗中的应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
日本心臓血管外科学会雑誌, (2015.07.15), 44, [4], P.241-244, JPN6020024632, ISSN: 0004447865 *

Also Published As

Publication number Publication date
CA2997946A1 (en) 2017-03-16
AU2016319292A1 (en) 2018-04-12
WO2017042370A1 (en) 2017-03-16
EP3347036A1 (en) 2018-07-18
US20190060407A1 (en) 2019-02-28

Similar Documents

Publication Publication Date Title
JP7561893B2 (ja) 自己免疫関連障害または炎症性障害の治療のための低用量ｉｌ－２の使用
Ferreli et al. Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review
Ship et al. Treatment of primary Sjogren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial
CA2688766C (en) Compositions and methods for treatment of multiple sclerosis
US11534479B2 (en) Use of interleukin 2 for treating Sjögren's syndrome
CA2997946A1 (en) Use of interleukin 2 for treating spondyloarthritis
US4946674A (en) Process for treatment of rheumatic diseases
EP3533451B1 (en) Application of paeoniflorin-6'-o-benzene sulfonate in medicine for treating sjögren's syndrome
WO2023051660A1 (zh) 用TACI-Fc融合蛋白治疗干燥综合征的方法
EP1471916B1 (en) Treatment of rheumatoid arthritis using imatinib
US20100234277A1 (en) Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease
WO2020007937A1 (en) Use of interleukin-2 for treating systemic sclerosis
Opoka-Winiarska et al. Current indications for the use of Janus kinase inhibitors in the treatment of juvenile idiopathic arthritis
US20050147588A1 (en) Methods for treatment of obesity and for promotion of weight loss
WO2011151372A1 (en) Treatment of rheumatoid arthritis with masitinib
JP5699030B2 (ja) エタネルセプトを含む線維筋痛症の治療剤
Wolska-Gawron et al. Localized scleroderma in children
Tur The European League Against Rheumatism (EULAR)-2020 Annual European E-Congress of Rheumatology. Virtual Conference-June 3-6, 2020
Williams et al. Chronic Graft-Versus-Host Disease.
JPH03291237A (ja) アレルギー性疾患治療用医薬組成物
MEMON et al. EFFICACY OF CYCLOSPORINE IN 36 PATIENTS WITH RHEUMATOID ARTHRITIS
Tsui Update in the Management of Ankylosing Spondylitis
HK1167101B (en) Compositions and methods for treatment of multiple sclerosis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190906

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190906

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200630

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200714

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210224